Shares of Indivior PLC (LON:INDV - Get Free Report) rose 11.1% during mid-day trading on Friday . The company traded as high as GBX 799 ($10.72) and last traded at GBX 772 ($10.35). Approximately 551,238 shares traded hands during trading, a decline of 49% from the average daily volume of 1,087,031 shares. The stock had previously closed at GBX 695 ($9.32).
Indivior Stock Performance
The firm has a market cap of £1.34 billion, a P/E ratio of -711.82, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The company's 50 day moving average is GBX 725.17 and its 200 day moving average is GBX 804.32.
Indivior Company Profile
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Stories
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
